Open Access. Powered by Scholars. Published by Universities.®
- Keyword
-
- Analysis of Variance (1)
- Anti-Infective Agents (1)
- Atherosclerosis (1)
- Atovaquone (1)
- Blood Vessels (1)
-
- Ceramide (1)
- Ceramides (1)
- Diet, Atherogenic (1)
- Diet, High-Fat (1)
- Disease Models, Animal (1)
- Fatty Acids (1)
- Feto-maternal Toxoplasmosis (1)
- Gastrointestinal (1)
- Gastrointestinal Tract (1)
- Hepatitis (1)
- Hyperalgesia (1)
- Immunohistochemistry (1)
- Lipoproteins, LDL (1)
- Liver (1)
- Low-density lipoprotein aggregation (1)
- Macrophages (1)
- Male (1)
- Mice, Inbred C57BL (1)
- Mice, Mutant Strains (1)
- Pancreatitis (1)
- Pregnancy (1)
- Receptors, Lipoprotein (1)
Articles 1 - 2 of 2
Full-Text Articles in Physiology
Characterization Of Secretory Sphingomyelinase Activity, Lipoprotein Sphingolipid Content And Ldl Aggregation In Ldlr-/- Mice Fed On A High-Fat Diet, Gergana M. Deevska, Manjula Sunkara, Andrew J. Morris, Mariana N. Nikolova‑Karakashian
Characterization Of Secretory Sphingomyelinase Activity, Lipoprotein Sphingolipid Content And Ldl Aggregation In Ldlr-/- Mice Fed On A High-Fat Diet, Gergana M. Deevska, Manjula Sunkara, Andrew J. Morris, Mariana N. Nikolova‑Karakashian
Physiology Faculty Publications
The propensity of LDLs (low-density lipoproteins) for aggregation and/or oxidation has been linked to their sphingolipid content, specifically the levels of SM (sphingomyelin) and ceramide. To investigate this association in vivo, ldlr (LDL receptor)-null mice (ldlr-/-) were fed on a modified (atherogenic) diet containing saturated fats and cholesterol. The diet led to significantly elevated SM content in all serum lipoproteins. In contrast, ceramide increased only in the LDL particles. MS-based analyses of the lipid acyl chain composition revealed a marked elevation in C16:0 fatty acid in SM and ceramide, consistent with the prevalence of palmitic acid in the modified diet. …
Atovaquone Ameliorate Gastrointestinal Toxoplasmosis Complications In A Pregnancy Model, Helieh S. Oz, Thomas Tobin
Atovaquone Ameliorate Gastrointestinal Toxoplasmosis Complications In A Pregnancy Model, Helieh S. Oz, Thomas Tobin
Physiology Faculty Publications
Background: Toxoplasma is an important source of foodborne hospitalization with no safe and effective therapy against chronic or congenital Toxopalsmosis. Atovaquone is a drug of choice but not approved for use in congenital Toxoplasmosis. We hypothesized atovaquone to be safe and effective against feto-maternal Toxoplasmosis.
Material/Methods: Programmed pregnant mice were i.p. infected with 50–2400 Tachyzoites from Type II strain (clone PTG). Dams were treated daily with atovaquone or sham and monitored for pain, and complications.
Results: Dams developed pain related abdominal hypersensitivity (allodynia) to mechanical stimuli in a Tachyzoites dose dependent manner. Infected dams were anemic and exhibited ascities and …